[Drug cytopenia with active antibodies in the presence of acetyl-salicylic acid and niflumic acid].
D000225:Adenine / Q000009:adverse effects; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis*; D000941:Antigens; D001241:Aspirin / Q000009:adverse effects; D001789:Blood Group Antigens; D001803:Blood Transfusion; D001856:Bone Marrow Examination; D011431:Dextropropoxyphene / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000150:complications / Q000276:immunology* / Q000628:therapy; D004906:Erythrocyte Count; D006801:Humans; D007518:Isoantibodies; D037102:Lectins / Q000627:therapeutic use; D007958:Leukocyte Count; D008297:Male; D008551:Melena / Q000209:etiology; D009539:Nicotinic Acids / Q000009:adverse effects; D012216:Rheumatic Diseases / Q000188:drug therapy; D014812:Vitamin K / Q000627:therapeutic use
D000700:Analgesics; D000906:Antibodies; D000941:Antigens; D001789:Blood Group Antigens; D007518:Isoantibodies; D037102:Lectins; D009539:Nicotinic Acids; D014812:Vitamin K; D000225:Adenine; D001241:Aspirin; D011431:Dextropropoxyphene
Cytopénie médicamenteuse avec anticorps actifs en présence d'acide acétyl-salycilique et d'acide niflumique.